Breast Cancer MSK 17-598 Discovery

The purpose of this study is to collect blood and tissue to help develop tests that might be able to detect cancer earlier. The investigator will be collecting these samples and reviewing test results from participants who have had an area of concern found on breast imaging, as well as from participants who are scheduled to have a routine breast cancer screening mammogram.

Eligibility Criteria:

Cohort I - BI-RADS 4 Cohort: Females with one or more BI-RADS 4 radiographic lesions who are undergoing ultrasound, stereotactic or MRI-guided breast biopsy at MSKCC or at an MSK Alliance Member Site. If multiple imaging modalities were employed (mammogram, ultrasound, MRI) and no integrated score is provided, then the highest BI-RADS score will be used. Age ≥ 18 years at the time of breast biopsy.

Cohort II - Reference Cohort A. Unselected BI-RADS 1/2 Cohort. Females undergoing screening mammogram at MSKCCAge ≥ 18 years at the time of mammogram.

This study is for patients age 18 and older.

Available at: Hartford Hospital, Hospital of Central Connecticut, Midstate Medical Center, Backus Hospital

Cancer Clinical Research Office